Long-term efficacy and safety of oral Viagra (R) (sildenafil citrate) in men with erectile dysfunction and the effect of randomised treatment withdrawal
E. Christiansen et al., Long-term efficacy and safety of oral Viagra (R) (sildenafil citrate) in men with erectile dysfunction and the effect of randomised treatment withdrawal, INT J IMPOT, 12(3), 2000, pp. 177-182
The long-term efficacy and safety of oral Viagra(R) (sildenafil citrate), a
selective phosphodiesterase 5 inhibitor, and the effect of withdrawing tre
atment were evaluated in men with erectile dysfunction (ED). In 233 men wit
h ED of psychogenic or mixed organic/psychogenic aetiology, 16 weeks of ope
n-label, flexible-dose sildenafil treatment (10 - 100 mg) was followed by e
ight weeks of double-blind, fixed-dose, randomised withdrawal to placebo or
continued treatment with sildenafil, Sildenafil was taken as needed (not m
ore than once daily) approximately Ih prior to sexual activity. The main ou
tcome measures were a global efficacy question, a sexual function questionn
aire, an event log of erections, and adverse event recording, In the open-l
abel phase, 200 of 216 patients (93%) reported improved erections with sild
enafil; 28 patients (12%) discontinued treatment. In the double-blind phase
, the significant improvements in the frequency and duration of erections w
ere maintained in the sildenafil group but returned to pre-treatment values
in patients on placebo (P values < 0.0001 versus placebo). The most Freque
nt adverse events in the sildenafil group during the double-blind phase wer
e flushing (7%), headache (6%), and dyspepsia (5%), Of the 192 patients enr
olled in the 1-y extension, 90% completed the study; only two patients (1%)
were withdrawn due to lack of efficacy. Tn men with ED of psychogenic or m
ixed aetiology, oral sildenafil is effective and well-tolerated both at the
initiation of therapy and during long-term treatment. For most patients, s
ildenafil treatment must be continued for improvements in erectile function
to be maintained.